Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,745 | -3,963 | -6,271 | -9,806 | N/A |
| Depreciation Amortization | 783 | 906 | 1,025 | 1,186 | N/A |
| Accounts receivable | N/A | N/A | 18 | N/A | N/A |
| Other Working Capital | -1,786 | 2,431 | -918 | 1,721 | N/A |
| Other Operating Activity | 1,106 | 3,455 | 115 | 54 | 0 |
| Operating Cash Flow | $-17,642 | $2,829 | $-6,031 | $-6,845 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -5 | 511 | 45 | N/A |
| Investing Cash Flow | $-42 | $-5 | $511 | $45 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,462 | 2,538 | N/A | N/A |
| Debt Repayment | N/A | -307 | -446 | -848 | N/A |
| Common Stock Issued | 57,990 | N/A | 141 | 2 | N/A |
| Other Financing Activity | 0 | 7,261 | 307 | 9,982 | 0 |
| Financing Cash Flow | $57,990 | $8,416 | $2,540 | $9,136 | $N/A |
| Beginning Cash Position | 12,357 | 1,117 | 4,097 | 1,761 | N/A |
| End Cash Position | 52,663 | 12,357 | 1,117 | 4,097 | N/A |
| Net Cash Flow | $40,306 | $11,240 | $-2,980 | $2,336 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,642 | 2,829 | -6,031 | -6,845 | N/A |
| Capital Expenditure | -42 | -5 | 0 | -15 | N/A |
| Free Cash Flow | -17,684 | 2,824 | -6,031 | -6,860 | 0 |